ONE Share Price Performance
AU$0.25
-0.09 (-26.47%)
41.0% undervalued intrinsic discount
AU$0.42
Fair Value
Price AU$0.25
AnalystConsensusTarget AU$0.42
Fair ValueAU$0.42
Share PriceAU$0.25
41.0% undervalued intrinsic discount
ONE Community Narratives
AN
Fair Value AU$0.42 41.0% undervalued intrinsic discount
Digital Patient Engagement And Cloud SaaS Will Expand Healthcare Reach
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
Recent ONE News & Updates
No updates
Oneview Healthcare PLC Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
Aug 12, 2025
- Earnings per share (EPS)
- -0.014
- Gross Margin
- 67.41%
- Net Profit Margin
- -109.52%
- Debt/Equity Ratio
- 0%
Oneview Healthcare PLC Competitors
About ONE
- Founded
- 2008
- Employees
- 96
- CEO
- WebsiteView website
Oneview Healthcare PLC develops and sells software services for the healthcare sector in Ireland, the United States, Australia, Ireland, the Middle East, and Asia. The company provides patient experience, care team experience, and health system and hospital solutions; and system integrations for HER/EMP/PAS, virtual care, interpretations, middleware, clinical communications, dietary, IoT: RTLS and building automation, patient education and portals, entertainment and gaming, calming and distraction, and consumer streaming and social. It offers secure software development lifecycle, data classification, and third-party penetration testing. The company was founded in 2008 and is based in Dublin, Ireland.
Irish Market Performance
- 7 Days: -1.2%
- 3 Months: 4.9%
- 1 Year: 21.8%
- Year to Date: 17.0%
Over the last 7 days, the market has dropped 1.2%, driven by a loss of 4.3% in the Consumer Staples sector. In the last year, the market is actually up 22%. Looking forward, earnings are forecast to grow by 7.1% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading